Table 1 Clinicopathological characteristics of 12 myxofibrosarcomas subjected to genomic profiling by array comparative genomic hybridization

From: Prognostic implication of MET overexpression in myxofibrosarcomas: an integrative array comparative genomic hybridization, real-time quantitative PCR, immunoblotting, and immunohistochemical analysis

Cases

Depth

Size (cm)

Myxoid areas (%)

Mitotic rate a

Atypical mitosis

Tumor necrosis

FNCLCC grade

AJCC stage

Status

MFSa1b

Deep

≥5, <10

10

13

Yes

Yes

2

3

Recurrent

MFS6c

Deep

≥5, <10

10

24

Yes

Yes

3

3

Recurrent

MFS7b

Deep

≥5, <10

55

12

No

No

2

3

Recurrent

MFS8b

Deep

≥10

35

10

Yes

Yes

2

3

Primary

MFS19b

Superficial

<5

60

2

No

No

1

2

Primary

MFS64

Deep

≥5, <10

60

8

Yes

Yes

2

3

Primary

MFS84b

Deep

≥5, <10

40

31

Yes

No

2

3

Recurrent

MFS86

Superficial

<5

45

6

Yes

No

1

2

Recurrent

MFS49a

Superficial

≥5, <10

50

45

Yes

Yes

3

2

Primary

MFS96b

Deep

≥5, <10

75

17

No

Yes

2

3

Recurrent

MFS99b

Deep

≥5, <10

10

24

Yes

Yes

3

3

Primary

MFS101

Deep

<5

95

1

No

No

1

1

Primary

  1. aPer 10 higher power fields.